Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02285127

Enrollment

168

Registered

2014-11-06

Start date

2014-11-30

Completion date

2019-09-30

Last updated

2023-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertrochanteric Hip Fracture

Brief summary

Is there a functional outcome difference when treating pertrochanteric fractures with a short or long cephalomedullary nail?

Interventions

PROCEDUREShort versus long cephalomedullary Intramedullary nail

Biomet Affixus Short and Long hip fracture nail. Stryker Gamma Short and Long hip fracture nail.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* AO/OTA fracture classification 31(A-B) (1-3). * Age greater than 18 years old.

Exclusion criteria

-Less than 18 years old.

Design outcomes

Primary

Measure	Time frame
SF (short form)-36	3 months

Secondary

Measure	Time frame
Harris Hip Score	3 months

Other

Measure	Time frame
Reoperation	within 1 year
Mortality	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026